Mouse models have been the workhorses of preclinical immuno-oncology (IO) research, and advances in mouse model development have expanded to applications for nearly all types of solid tumors and hematological malignancies. Preclinical evaluation of experimental immunotherapies has been advanced by syngeneic and humanized mouse models.
Choosing the RIGHT Model - Syngeneic versus Humanized Mouse Models
Feb 2, 2023 11:49:07 AM / by Champions Oncology posted in Syngeneic Models, Immuno-Oncology, Humanized Models
Subscribe to Champions’ Scientific Blog
Posts by Topic
- Solid Tumor Oncology (46)
- Hematological Malignancies (22)
- Immuno-Oncology (13)
- Clinical Flow Cytometry (11)
- Ex Vivo Platforms (10)
- Lumin Bioinformatics (10)
- NGS (8)
- Humanized Models (7)
- IHC (7)
- Preclinical Flow Cytometry (5)
- Preclinical In Vivo Imaging (5)
- Syngeneic Models (5)
- Translational Oncology (2)
- Western Blot (2)
- Flow Cytometry (1)
- Next Generation Sequencing (1)